| Bharat Immunological & Biological Corporation Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524663 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE994B01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -7.54 |
Market Cap(₹Cr) : 89.17 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.00 | 0.00 | 7.65 | 0.00 | 26.48 | 10.48 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 7.65 | 0.00 | 26.48 | 10.48 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.16 | 0.10 | 0.49 | 0.10 | 0.32 | 0.14 |
| Total Income | 0.16 | 0.10 | 8.15 | 0.10 | 26.80 | 10.62 |
| Total Expenditure | 4.69 | 4.31 | 11.67 | 4.73 | 28.98 | 15.31 |
| PBIDT | -4.52 | -4.21 | -3.53 | -4.62 | -2.18 | -4.69 |
| Interest | 2.09 | 1.72 | 2.06 | 1.67 | 1.74 | 1.58 |
| PBDT | -6.61 | -5.93 | -5.59 | -6.29 | -3.92 | -6.27 |
| Depreciation | 0.03 | 0.03 | 0.09 | 0.04 | 0.04 | 0.04 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.73 | -1.38 | -1.80 | -1.65 | -0.88 | -1.31 |
| Reported Profit After Tax | -4.92 | -4.59 | -3.88 | -4.68 | -3.08 | -5.00 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -4.92 | -4.59 | -3.88 | -4.68 | -3.08 | -5.00 |
| EPS (Unit Curr.) | -1.14 | -1.06 | -0.90 | -1.08 | -0.71 | -1.16 |
| EPS (Adj) (Unit Curr.) | -1.14 | -1.06 | -0.90 | -1.08 | -0.71 | -1.16 |
| Calculated EPS (Unit Curr.) | -1.14 | -1.06 | -0.90 | -1.08 | -0.71 | -1.16 |
| Calculated EPS (Adj) (Unit Curr.) | -1.14 | -1.06 | -0.90 | -1.08 | -0.71 | -1.16 |
| Calculated EPS (Ann.) (Unit Curr.) | -4.56 | -4.25 | -3.59 | -4.34 | -2.86 | -4.63 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -4.56 | -4.25 | -3.59 | -4.34 | -2.86 | -4.63 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 17,594,000.00 | 17,594,000.00 | 0.00 | 17,594,000.00 | 17,594,000.00 | 17,594,000.00 |
| Public Shareholding (% in Equity) | 40.75 | 40.75 | 0.00 | 40.75 | 40.75 | 40.75 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 25,586,000.00 | 25,586,000.00 | 0.00 | 25,586,000.00 | 25,586,000.00 | 25,586,000.00 |
| Non Encumbered - % in Total Promoters Holding | 100.00 | 100.00 | 0.00 | 100.00 | 100.00 | 100.00 |
| Non Encumbered - % in Total Equity | 59.25 | 59.25 | 0.00 | 59.25 | 59.25 | 59.25 |
| PBIDTM(%) | 0.00 | 0.00 | -46.14 | 0.00 | -8.23 | -44.75 |
| PBDTM(%) | 0.00 | 0.00 | -73.07 | 0.00 | -14.80 | -59.83 |
| PATM(%) | 0.00 | 0.00 | -50.72 | 0.00 | -11.63 | -47.71 |